Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

IN8BIO, INC. Director's Dealing 2026

Feb 6, 2026

35200_dirs_2026-02-06_ebd6b43c-5853-4f59-9cd1-337be83e5cb6.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: IN8BIO, INC. (INAB)
CIK: 0001740279
Period of Report: 2026-02-04

Reporting Person: Ho William Tai-Wei (N/A)

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2026-02-04 Employee Stock Option (right to buy) $1.96 A 206000 Acquired 2036-02-04 Common Stock (206000) Direct

Footnotes

F1: Twenty-five percent (25%) of the shares subject to the option shall vest on February 4, 2027 and the remaining shares subject to the option shall vest in thirty-six (36) equal monthly installments thereafter, subject to the Reporting Person continuing to provide service through each such date.